Successful Binding of Peroxide Sensitive APIs

Attend to recieve a FREE executive summary of the webcastOn Demand Webinar
Recorded: Tuesday, July 7th 2015

Register Free at www.pharmtech.com/pt/peroxide

EVENT OVERVIEW

The formulation of peroxide sensitive active ingredients (API) is a growing topic. Not only novel APIs are often subject to peroxide-induced deterioration, also reformulation or repacking of existing APIs for increased patient compliance often faces the issue of potential peroxide interaction caused by the binder used. In this webinar, we will show

  • That Kollicoat IR forms no peroxides at all
  • That it’s binding capability is at least as good as the one of PVP, often even better
  • And that it can be used in standard granulation equipment.
Key Learning Objectives
Why Kollicoat IR is a powerful binder and that it practically does not form peroxides.
In which commonly used production processes it can be applied.
How easy it is to be processed.
Who Should Attend
This webinar targets all formulators looking for a solution to finally combine excellent binding properties with no peroxide exposure – not only until packaging, or until the bottle or blister is opened, but throughout the whole lifecycle of the drug – from production to patient administration.
Presenters
Bernhard Fussnegger
Global Development & Technical Marketing
BASF SE
Jan Bebber
Platform Marketing Pharma Ingredients
BASF SE
Moderator:
Rita Peters
Editorial Director
Pharmaceutical Technology
Sponsored by Presented by
BASF logo PharmTech logo
For questions, contact Sara Barschdorf at sbarschdorf@advanstar.com
spacer for layout
PharmTechspacer for layoutspacer for layoutSUBSCRIBE: PRINT| DIGITAL | ENEWS
LinkedInTwitterspacer for layout